Palli, Rohith
Seaton, Kelly E.
Piepenbrink, Michael S.
Hural, John
Goepfert, Paul A.
Laher, Fatima
Buchbinder, Susan P.
Churchyard, Gavin
Gray, Glenda E.
Robinson, Harriet L.
Huang, Yunda
Janes, Holly
Kobie, James J.
Keefer, Michael C.
Tomaras, Georgia D.
Thakar, Juilee
Funding for this research was provided by:
U.S. National Library of Medicine (F31LM012893)
National Institute of General Medical Sciences (T32GM07356)
National Institute of Allergy and Infectious Diseases (UM1AI068614, 5R01AI117787)
Article History
Received: 8 April 2020
Accepted: 16 June 2020
First Online: 3 August 2020
Competing interests
: HLR is an inventor on U.S. Patents 7,795,017, 8,623,379, 7,867,982 and 9,453,239 addressing DNA and MVA immunogens being developed for a Clade B HIV vaccine.